Companies /Healthcare

Satellos Bioscience Inc. Common Stock

NASDAQ: MSLE Biotechnology
$9.49
â–² $0.13 (+1.34%) today
Markets open · 1:36pm ET
Today · % change

Fundamentals

Market Cap
$198.6M
EPS (TTM)
$-1.94
52-Week Range
$5 – $13
Street Target
$26.25

About MSLE

Satellos Bioscience Inc., a biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia. The company is headquartered in Toronto, Canada.

MSLE Coverage